Testing effectiveness (Phase 2)Study completedNCT03194776
What this trial is testing
Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication
Who this might be right for
Peripheral Artery Disease (PAD); Intermittent Claudication
Novartis Pharmaceuticals 46